83 related articles for article (PubMed ID: 8934229)
1. Retroviral display of antibody fragments; interdomain spacing strongly influences vector infectivity.
Ager S; Nilson BH; Morling FJ; Peng KW; Cosset FL; Russell SJ
Hum Gene Ther; 1996 Nov; 7(17):2157-64. PubMed ID: 8934229
[TBL] [Abstract][Full Text] [Related]
2. Improvement of retroviral retargeting by using amino acid spacers between an additional binding domain and the N terminus of Moloney murine leukemia virus SU.
Valsesia-Wittmann S; Morling FJ; Nilson BH; Takeuchi Y; Russell SJ; Cosset FL
J Virol; 1996 Mar; 70(3):2059-64. PubMed ID: 8627737
[TBL] [Abstract][Full Text] [Related]
3. Expression of chimeric envelope proteins in helper cell lines and integration into Moloney murine leukemia virus particles.
Schnierle BS; Moritz D; Jeschke M; Groner B
Gene Ther; 1996 Apr; 3(4):334-42. PubMed ID: 8732165
[TBL] [Abstract][Full Text] [Related]
4. Retroviral vector targeting to melanoma cells by single-chain antibody incorporation in envelope.
Martin F; Kupsch J; Takeuchi Y; Russell S; Cosset FL; Collins M
Hum Gene Ther; 1998 Mar; 9(5):737-46. PubMed ID: 9551621
[TBL] [Abstract][Full Text] [Related]
5. Retroviral display of functional binding domains fused to the amino terminus of influenza hemagglutinin.
Hatziioannou T; Delahaye E; Martin F; Russell SJ; Cosset FL
Hum Gene Ther; 1999 Jun; 10(9):1533-44. PubMed ID: 10395378
[TBL] [Abstract][Full Text] [Related]
6. Masking of retroviral envelope functions by oligomerizing polypeptide adaptors.
Morling FJ; Peng KW; Cosset FL; Russell SJ
Virology; 1997 Jul; 234(1):51-61. PubMed ID: 9234946
[TBL] [Abstract][Full Text] [Related]
7. Efficient gene delivery to quiescent interleukin-2 (IL-2)-dependent cells by murine leukemia virus-derived vectors harboring IL-2 chimeric envelope glycoproteins.
Maurice M; Mazur S; Bullough FJ; Salvetti A; Collins MK; Russell SJ; Cosset FL
Blood; 1999 Jul; 94(2):401-10. PubMed ID: 10397706
[TBL] [Abstract][Full Text] [Related]
8. Targeting retroviral vectors to CD34-expressing cells: binding to CD34 does not catalyze virus-cell fusion.
Benedict CA; Tun RY; Rubinstein DB; Guillaume T; Cannon PM; Anderson WF
Hum Gene Ther; 1999 Mar; 10(4):545-57. PubMed ID: 10094198
[TBL] [Abstract][Full Text] [Related]
9. Specifically targeted killing of carcinoembryonic antigen (CEA)-expressing cells by a retroviral vector displaying single-chain variable fragmented antibody to CEA and carrying the gene for inducible nitric oxide synthase.
Khare PD; Shao-Xi L; Kuroki M; Hirose Y; Arakawa F; Nakamura K; Tomita Y; Kuroki M
Cancer Res; 2001 Jan; 61(1):370-5. PubMed ID: 11196189
[TBL] [Abstract][Full Text] [Related]
10. A gene delivery system activatable by disease-associated matrix metalloproteinases.
Peng KW; Morling FJ; Cosset FL; Murphy G; Russell SJ
Hum Gene Ther; 1997 Apr; 8(6):729-38. PubMed ID: 9113512
[TBL] [Abstract][Full Text] [Related]
11. A hyperfusogenic gibbon ape leukemia envelope glycoprotein: targeting of a cytotoxic gene by ligand display.
Fielding AK; Chapel-Fernandes S; Chadwick MP; Bullough FJ; Cosset FL; Russell SJ
Hum Gene Ther; 2000 Apr; 11(6):817-26. PubMed ID: 10779159
[TBL] [Abstract][Full Text] [Related]
12. Retroviral vectors displaying functional antibody fragments.
Russell SJ; Hawkins RE; Winter G
Nucleic Acids Res; 1993 Mar; 21(5):1081-5. PubMed ID: 8385311
[TBL] [Abstract][Full Text] [Related]
13. Insertion of targeting domains into the envelope glycoprotein of Moloney murine leukemia virus (MoMLV)-based vectors modulates the route of mCAT-1-mediated viral entry.
Viejo-Borbolla A; Pizzato M; Blair ED; Schulz TF
Virus Res; 2005 Mar; 108(1-2):45-55. PubMed ID: 15681054
[TBL] [Abstract][Full Text] [Related]
14. Cell type-specific targeting with sindbis pseudotyped lentiviral vectors displaying anti-CCR5 single-chain antibodies.
Aires da Silva F; Costa MJ; Corte-Real S; Goncalves J
Hum Gene Ther; 2005 Feb; 16(2):223-34. PubMed ID: 15761262
[TBL] [Abstract][Full Text] [Related]
15. The insertion of an anti-MHC I ScFv into the N-terminus of an ecotropic MLV glycoprotein does not alter its fusiogenic potential on murine cells.
Karavanas G; Marin M; Bachrach E; Papavassiliou AG; Piechaczyk M
Virus Res; 2002 Feb; 83(1-2):57-69. PubMed ID: 11864741
[TBL] [Abstract][Full Text] [Related]
16. A new yeast display vector permitting free scFv amino termini can augment ligand binding affinities.
Wang Z; Mathias A; Stavrou S; Neville DM
Protein Eng Des Sel; 2005 Jul; 18(7):337-43. PubMed ID: 15976011
[TBL] [Abstract][Full Text] [Related]
17. Targeted entry via somatostatin receptors using a novel modified retrovirus glycoprotein that delivers genes at levels comparable to those of wild-type viral glycoproteins.
Li F; Ryu BY; Krueger RL; Heldt SA; Albritton LM
J Virol; 2012 Jan; 86(1):373-81. PubMed ID: 22013043
[TBL] [Abstract][Full Text] [Related]
18. Antibody-mediated targeting of replication-competent retroviral vectors.
Tai CK; Logg CR; Park JM; Anderson WF; Press MF; Kasahara N
Hum Gene Ther; 2003 May; 14(8):789-802. PubMed ID: 12804141
[TBL] [Abstract][Full Text] [Related]
19. Tumor cell-specific gene transfer with retroviral vectors displaying single-chain antibody.
Tang Y; Li Y; Qian G
Chin Med J (Engl); 2002 Jul; 115(7):1064-9. PubMed ID: 12150744
[TBL] [Abstract][Full Text] [Related]
20. Retroviral vector sequences may interact with some internal promoters and influence expression.
Wu X; Holschen J; Kennedy SC; Ponder KP
Hum Gene Ther; 1996 Jan; 7(2):159-71. PubMed ID: 8788167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
